Low Dose Chest CT and Lung Ultrasound for the Diagnosis and Management of COVID-19

Julie Finance; Laurent Zieleskewicz; Paul Habert; Alexis Jacquier; Philippe Parola; Alain Boussuges; Fabienne Bregeon; Carole Eldin

doi:10.3390/jcm10102196

Journal articles

Low Dose Chest CT and Lung Ultrasound for the Diagnosis and Management of COVID-19

Julie Finance ¹ Laurent Zieleskewicz ^{2, 3} Paul Habert ^{4, 5} Alexis Jacquier ^{6, 7} Philippe Parola ^{8, 9} Alain Boussuges ² Fabienne Bregeon ¹⁰ Carole Eldin ^{8, 9}

1 Service des explorations fonctionnelles respiratoires [Hôpital Nord - APHM]

2 C2VN - Centre recherche en CardioVasculaire et Nutrition = Center for CardioVascular and Nutrition research

3 Service de Radiologie Cardio-Thoracique, Hôpital La Timone,

4 Département de Cardiologie [Hôpital de la Timone - APHM]

5 LIIE - Laboratoire d'Imagerie Interventionnelle Expérimentale

6 Service de Radiologie Cardio-Thoracique, Hôpital La Timone

7 CRMBM-CEMEREM - Centre de Résonance Magnétique Biologique et Médicale-Centre d'Exploration Métaboliques par Résonance Magnétique

8 VITROME - Vecteurs - Infections tropicales et méditerranéennes

9 IHU Marseille - Institut Hospitalier Universitaire Méditerranée Infection

10 MEPHI - Microbes évolution phylogénie et infections

Abstract : Background: The COVID-19 pandemic has provided an opportunity to use low- and non-radiating chest imaging techniques on a large scale in the context of an infectious disease, which has never been done before. Previously, low-dose techniques were rarely used for infectious diseases, despite the recognised danger of ionising radiation. Method: To evaluate the role of low-dose computed tomography (LDCT) and lung ultrasound (LUS) in managing COVID-19 pneumonia, we performed a review of the literature including our cases. Results: Chest LDCT is now performed routinely when diagnosing and assessing the severity of COVID-19, allowing patients to be rapidly triaged. The extent of lung involvement assessed by LDCT is accurate in terms of predicting poor clinical outcomes in COVID-19-infected patients. Infectious disease specialists are less familiar with LUS, but this technique is also of great interest for a rapid diagnosis of patients with COVID-19 and is effective at assessing patient prognosis. Conclusions: COVID-19 is currently accelerating the transition to low-dose and “no-dose” imaging techniques to explore infectious pneumonia and their long-term consequences.

Document type :

Journal articles

Domain :

Life Sciences [q-bio] / Microbiology and Parasitology / Bacteriology

Life Sciences [q-bio] / Microbiology and Parasitology / Virology

Life Sciences [q-bio] / Microbiology and Parasitology / Parasitology

Life Sciences [q-bio] / Human health and pathology / Cardiology and cardiovascular system

Life Sciences [q-bio] / Human health and pathology / Emerging diseases

Life Sciences [q-bio] / Human health and pathology / Infectious diseases

Complete list of metadata

https://hal-amu.archives-ouvertes.fr/hal-03282013
Contributor : Isabelle Combe <>
Submitted on : Thursday, July 8, 2021 - 4:13:03 PM
Last modification on : Thursday, August 5, 2021 - 4:04:41 PM

Low Dose Chest CT and Lung Ultrasound for the Diagnosis and Management of COVID-19

Links full text

Identifiers

Collections

Citation

Export

Metrics

20

Low Dose Chest CT and Lung Ultrasound for the Diagnosis and Management of COVID-19

Links full text

Identifiers

Collections

Citation

Export

Share

Metrics

20